The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Polyradiculoneuropathy


High impact information on Polyradiculoneuropathy


Chemical compound and disease context of Polyradiculoneuropathy


Biological context of Polyradiculoneuropathy


Anatomical context of Polyradiculoneuropathy


Gene context of Polyradiculoneuropathy


  1. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Hartung, H.P., Reiners, K., Schmidt, B., Stoll, G., Toyka, K.V. Ann. Neurol. (1991) [Pubmed]
  2. T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Hartung, H.P., Hughes, R.A., Taylor, W.A., Heininger, K., Reiners, K., Toyka, K.V. Neurology (1990) [Pubmed]
  3. Acute axonal form of Guillain-Barré syndrome in a multiple sclerosis patient: chance association or linked disorders? Capello, E., Roccatagliata, L., Schenone, A., Gazzola, P., Inglese, M., Abbruzzese, M., Mancardi, G.L. Eur. J. Neurol. (2000) [Pubmed]
  4. Polyradiculoneuropathy accompanying procainamide-induced lupus erythematosus: evidence for drug-induced enhanced sensitization to peripheral nerve myelin. Sahenk, Z., Mendell, J.R., Rossio, J.L., Hurtubise, P. Ann. Neurol. (1977) [Pubmed]
  5. Systemic lupus erythematosus with anti-Hu antibodies and polyradiculoneuropathy. Carpentier, A.F., Chassande, B., Amoura, Z., Benyahia, B., Piette, J.C., Delattre, J.Y. Neurology (2001) [Pubmed]
  6. Latency and duration of the muscle silent period following transcranial magnetic stimulation in multiple sclerosis, cerebral ischemia, and other upper motoneuron lesions. Haug, B.A., Kukowski, B. Neurology (1994) [Pubmed]
  7. Spontaneous and experimental neuritis and the distribution of the myelin protein P2 in the nervous system. Kadlubowski, M., Hughes, R.A., Gregson, N.A. J. Neurochem. (1984) [Pubmed]
  8. Little change in cerebrospinal fluid amino acids in subtypes of multiple sclerosis compared with acute polyradiculoneuropathy. Gårseth, M., White, L.R., Aasly, J. Neurochem. Int. (2001) [Pubmed]
  9. Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. Hodgkinson, S.J., Pollard, J.D., McLeod, J.G. J. Neurol. Neurosurg. Psychiatr. (1990) [Pubmed]
  10. Severe sensorimotor polyradiculoneuropathy after ingestion of ethylene glycol. Broadley, S.A., Ferguson, I.T., Walton, B., Tomson, C.R. J. Neurol. Neurosurg. Psychiatr. (1997) [Pubmed]
  11. Neuropathies associated with malignancy. Amato, A.A., Collins, M.P. Seminars in neurology. (1998) [Pubmed]
  12. Apoptosis in neurones exposed to cerebrospinal fluid from patients with multiple sclerosis or acute polyradiculoneuropathy. Øren, A., White, L.R., Aasly, J. J. Neurol. Sci. (2001) [Pubmed]
  13. Chronic relapsing polyradiculoneuropathy in IgG lambda monoclonal gammopathy of undetermined significance (MGUS)--complete remission following carmustine treatment. Wöber, C., Schmidbauer, M., Podreka, I., Wenger, S., Pafflmeyer, N., Deecke, L. Wien. Klin. Wochenschr. (1995) [Pubmed]
  14. Recurrent polyradiculoneuropathy and PMP22 defects. Wang, Y.J., Kao, K.P., Lin, K.P. Journal of the Chinese Medical Association : JCMA. (2005) [Pubmed]
  15. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy. Vedeler, C.A., Matre, R., Nyland, H. Acta neurologica Scandinavica. (1988) [Pubmed]
  16. Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. Kurz, M., Pischel, H., Hartung, H.P., Kieseier, B.C. J. Peripher. Nerv. Syst. (2005) [Pubmed]
  17. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. Fredman, P., Vedeler, C.A., Nyland, H., Aarli, J.A., Svennerholm, L. J. Neurol. (1991) [Pubmed]
  18. Disorder resembling Guillain-Barré syndrome on initiation of statin therapy. Rajabally, Y.A., Varakantam, V., Abbott, R.J. Muscle Nerve (2004) [Pubmed]
  19. Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia. Burguera, J.A., Villaroya, T., López-Alemany, M. Clinical neuropharmacology. (2000) [Pubmed]
  20. Paralytic illness resembling inflammatory polyradiculoneuropathy in a chimpanzee. Alford, P.L., Satterfield, W.C. J. Am. Vet. Med. Assoc. (1995) [Pubmed]
WikiGenes - Universities